Trials / Completed
CompletedNCT05632341
GCWB1176 Evaluates the Effectiveness and Safety of Immune Function
GCWB1176 8 Weeks, Multi -Tube, Randomized Assignment, Double -Eye, Placebo Control Human Application Test for Evaluating the Effectiveness and Safety of the Immune Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Green Cross Wellbeing · Industry
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This human application test was planned to evaluate the effectiveness and safety of immunodefinition compared to the placebo when the GCWB1176 was consumed for those whose white blood cell level was normal or somewhat decreased.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lactococcus lactis | 1 capsule once a day |
| OTHER | maltodextrin | 1 capsule once a day |
Timeline
- Start date
- 2023-01-17
- Primary completion
- 2024-01-31
- Completion
- 2024-03-31
- First posted
- 2022-11-30
- Last updated
- 2026-02-23
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05632341. Inclusion in this directory is not an endorsement.